Abstract
Coronavirus-19 is a severe acute respiratory disorder in humans which has become a major health problem. It spreads out very rapidly throughout the world since it has been first identified in Wuhan, China (December 2019). The causative virus is known as severe acute respiratory syndrome coronavirus 2. And the World Health Organization has named this respiratory syndrome as a new epidemic disease called COVID-19. The incidence of COVID-19 continued to increase with three million confirmed infected cases and with 244,000 death cases worldwide. Until now there is no specific treatment or vaccine available against COVID- 19. The collective information about the different aspects of COVID-19 viral infection has been gathered from renowned journals, and electronic databases including Science Direct, Web of Science, Scopus and PubMed from 1990 to 2020. This manuscript has highlighted the transmission and symptoms of Covid-19. Therefore, these studies show how the SARS-CoV 2 can facilitate the debut of the virus into targeted host cells.
Keywords: Coronavirus, ACE2, replication, target, protein, spike.
Graphical Abstract
Current Pharmaceutical Biotechnology
Title:Pathogenesis of COVID-19, Disease Outbreak: A Review
Volume: 22 Issue: 12
Author(s): Himanshu Sharma*, Sonia Singh and Shilpi Pathak
Affiliation:
- Department of Computer Engineering & Applications GLA University, 17km Stone, NH-2, Mathura-Delhi Road Mathura, Chaumuhan, Uttar Pradesh-281406,India
Keywords: Coronavirus, ACE2, replication, target, protein, spike.
Abstract: Coronavirus-19 is a severe acute respiratory disorder in humans which has become a major health problem. It spreads out very rapidly throughout the world since it has been first identified in Wuhan, China (December 2019). The causative virus is known as severe acute respiratory syndrome coronavirus 2. And the World Health Organization has named this respiratory syndrome as a new epidemic disease called COVID-19. The incidence of COVID-19 continued to increase with three million confirmed infected cases and with 244,000 death cases worldwide. Until now there is no specific treatment or vaccine available against COVID- 19. The collective information about the different aspects of COVID-19 viral infection has been gathered from renowned journals, and electronic databases including Science Direct, Web of Science, Scopus and PubMed from 1990 to 2020. This manuscript has highlighted the transmission and symptoms of Covid-19. Therefore, these studies show how the SARS-CoV 2 can facilitate the debut of the virus into targeted host cells.
Export Options
About this article
Cite this article as:
Sharma Himanshu *, Singh Sonia and Pathak Shilpi, Pathogenesis of COVID-19, Disease Outbreak: A Review, Current Pharmaceutical Biotechnology 2021; 22 (12) . https://dx.doi.org/10.2174/1389201022666210127113441
DOI https://dx.doi.org/10.2174/1389201022666210127113441 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Metabolism and Interactions of Chloroquine and Hydroxychloroquine with Human Cytochrome P450 Enzymes and Drug Transporters
Current Drug Metabolism CT Diagnosis of Coronavirus Infection
Current Medical Imaging Elucidating the Pivotal Role of Immune Players in the Management of COVID-19: Focus on Mesenchymal Stem Cells and Inflammation
Current Stem Cell Research & Therapy Patients with Rheumatic Diseases Overlooked during COVID-19 Pandemic: How are They Doing and Behaving?
Current Rheumatology Reviews B Cells: Programmers of CD4 T Cell Responses
Infectious Disorders - Drug Targets Patent Selections
Recent Patents on Anti-Infective Drug Discovery Magnetic Digital Microfluidics for Point-of-Care Testing: Where Are We Now?
Current Medicinal Chemistry A Note on Estimating the Case Fatality Ratio for Novel Corona Virus Disease (COVID-19)
Coronaviruses Knowledge Evaluation of Hand Hygiene and Infectious Diseases in Lebanon
Coronaviruses Bioinformatics-Based Characterization of Proteins Related to SARS-CoV- 2 Using the Polarity Index Method<sup>®</sup> (PIM<sup>®</sup>) and Intrinsic Disorder Predisposition
Current Proteomics Possible Therapeutic Interventions in COVID-19 Induced ARDS by Cotinine as an ACE-2 Promoter and AT-1R Blocker
Infectious Disorders - Drug Targets Coronavirus Disease-19 (COVID-19): Systematic Analysis of the Situation in Pakistan-Responses and Potential Advancements
Anti-Infective Agents Do We have the Evidence to Repurpose Levamisole for Treatment of COVID 19?
Current Drug Therapy Improving the Stability of Aptamers by Chemical Modification
Current Medicinal Chemistry Predicting the Metabolic Pathways of Small Molecules Based on Their Physicochemical Properties
Protein & Peptide Letters Remdesivir, A Potential Drug for COVID-19 Treatment: A New Hope
Coronaviruses Antiviral Effects of Asian Natural Products Targeting SARS, MERS, and COVID-19
Coronaviruses BCG Vaccination Program Mitigates COVID19 Related Mortality: A Reality Check
Current Pharmaceutical Biotechnology Diagnostic Value of Chest CT in Coronavirus Disease 2019 (COVID-19)
Current Medical Imaging A Coadunation of Biological and Mathematical Perspectives on the Pandemic COVID-19: A Review
Coronaviruses